Net Sales are expected to decrease by 6.4 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs. 6,676.9 crore, according to Edelweiss.
Edelweiss has come out with its fourth quarter (Jan-March’ 18) earnings estimates for the Pharma sector. The brokerage house expects Sun Pharma to report net profit at Rs. 745.2 crore down 39.1% year-on-year (down 15.2% quarter-on-quarter).
Net Sales are expected to decrease by 6.4 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs. 6,676.9 crore, according to Edelweiss.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 7.8 percent Y-o-Y (down 1.8 percent Q-o-Q) to Rs. 1,427 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.